| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Consolidated Net Income | $177.3M (+30% YoY Q3) | $188.3M (+35% YoY Q4) | +500 bps acceleration in growth |
| FSG Net Sales | $802.7M (+18% YoY Q3) | $834.4M (+21% YoY Q4) | +300 bps acceleration |
| FSG Operating Margin | 24.7% (vs 22.5% prior year) | 24.1% (vs 22.3% prior year) | -60 bps sequential but still above guidance |
| FSG Organic Growth | 13% (Q3) | 16% (Q4) | +300 bps acceleration |
| ETG Net Sales | $355.9M (+10% YoY Q3) | $384.8M (+14% YoY Q4) | +400 bps acceleration |
| ETG Operating Margin | 22.8% (vs 23.5% prior year) | 23.3% (vs 24.3% prior year) | +50 bps sequential recovery |
| Cash Flow from Operations | $231.2M (+8% YoY Q3) | $295.3M (+44% YoY Q4) | Massive +3600 bps acceleration |
| EBITDA | $316.4M (+21% YoY Q3) | $331.4M (+26% YoY Q4) | +500 bps acceleration |
| Net Debt-to-EBITDA | 1.9x (July 2025) | 1.60x (Oct 2025) | 30 bps deleveraging |
| FSG EBITA Margin | 27.3% (vs 25.2% prior year) | 26.6% (vs 25.0% prior year) | -70 bps sequential but solid YoY |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.